Steris (NYSE:STE) shares ticked up today on fourth-quarter financial results that came in just ahead of the consensus forecast.
The infection prevention technology company — headquartered in Dublin, Ireland and run operationally out of Mentor, Ohio — posted profits of $52.3 million, or 52¢ per share, on sales of $1.2 billion for the three months ended March 31, 2022, for a 40.2% bottom-line slide on sales growth of 37.4%.
Adjusted to exclude one-time items, earnings per share were $2.04, 2¢ ahead of Wall Street, where analysts were looking for sales of $1.19 billion.
The company’s healthcare segment’s revenues grew by 32% year-over-year, while applied sterilization technologies grew by 19% and life sciences grew by 15%. Dental revenues of $105.7 million were below expectations primarily due to COVID-19 impacts on patient volumes and higher supply chain and inflationary costs.
“We are pleased to end the year with strong performance in t…